Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures +0.09%, Hang Seng Futures +0.32%, ASX SPI 200 (0.13%), S&P Futures +0.12%

Aug 21 ,2025

  • Synopsis:

    • Asia equities poised to open mostly in positive territory Friday. Futures in Japan and Hong Kong traded higher, while Australia lagged. Japan ADRs were broadly weaker while Golden Dragon China index rose 1.35%. US contracts somewhat firmer following moderate declines in the cash session, though off worst levels. Tech leads were negative, particularly in terms of breath -- SOX index fell 0.49% with almost all US Big Tech lower. Treasuries weaker across the curve, with yields up 3-5 bp. Dollar index up 0.4%. Gold finished down 0.2%. Bitcoin futures off 2%. WTI crude ended up 1.3%.

    • Fed now squarely in focus ahead of Powell's speech at the Jackson Hole Symposium. September rate cut expectations fell below 80% after latest hawkish Fedspeak and upside surprise in US flash PMIs. Some mixed signals against other data with higher jobless claims garnering most of the attention. With a September cut remaining the baseline scenario, risks skewed hawkish if Powell emphasizes elevated inflation and outlook uncertainty. Volatility from any surprise apt to be compounded by seasonally thin August volumes. Recent Mag7/AI/growth/momentum underperformance continues to get a lot of attention with yesterday's pullback partly attributed to renewed scrutiny surrounding the payout from AI investments. Markets still bracing for announcement of US chip tariffs potentially in the triple digits, which President Trump flagged could be announced this week. US and EU reached framework agreement on trade, though largely on the back burner at this point.

    • Asia markets set to bide time ahead of Jackson Hole with the regional macro calendar light. Japan core inflation eased further, mostly in line with expectations and consistent with earlier Tokyo figures, mainly reflecting government energy subsidies. Attention remains on non-fresh food price pressures; rice surge moderated though aggregate still edged higher. Yet, data impacting BOJ policy expectations only on the margins with consensus looking for a rate hike by year-end and largely viewed as a matter of timing. Latest Reuters consensus leaned in favor of October. BOJ speculation was attributed as the underlying driver behind latest uptick in 10y JGB yields, hitting a 17-year high 1.61% Thursday. Notable Asia themes have died down this week after earnings season concluded. Disappointing China activity data was the key data surprise this week, though reverberations have been limited.

  • Pre-open Company News:

    • 2809.TT -- SinoPac Financial Holdings Co. to issue 1.38B shares for acquisition of King's Town Bank

    • 7751.JP -- Canon to conduct up to 11.4M-share off-auction buyback for up to ¥50.11B at ¥4,382/share 08:45 JT on 22-Aug

    • 300454.CH -- Sangfor Technologies reports H1 net income attributable (CNY227.6M) vs year-ago (CNY591.9M)

    • 603707.CH -- Nanjing King-friend Biochemical Pharmaceutical Co. receives FDA drug registration approval for Nicardipine Hydrochloride injection

    • 002373.CH -- China TransInfo Technology reports H1 net income attributable CNY169.7M vs guidance CNY150.0-200.0M and year-ago CNY12.2M

    • 600483.CH -- Fujian Funeng confirms H1 result, as reported on 25-Jul

    • 000958.CH -- SPIC Industry Finance Holdings reports H1 net income attributable CNY458.9M, (13%) vs year-ago CNY530.0M

    • 603160.CH -- Shenzhen Goodix Technology reports H1 net income attributable CNY430.6M, +36% vs year-ago CNY317.2M

    • 601567.CH -- Ningbo Sanxing Medical Electric reports H1 net income attributable CNY1.23B, +7% vs year-ago CNY1.15B

    • 9923.HK -- Yeahka reports H1 net income attributable CNY43.1M, +36% vs year-ago CNY31.6M

    • 1024.HK -- Kuaishou Technology reports Q2 adjusted net income CNY5.62B vs FactSet CNY5.04B

    • 600216.CH -- NMPA approves clinical trial of Zhejiang Medicine's XC2309 injection

    • 9690.HK -- Tuhu Car reports H1 adjusted net income CNY410.5M vs FactSet CNY363M

    • 688188.CH -- Shanghai BOCHU Electronic Technology Corp. reports H1 net income attributable CNY640.1M, +30% vs year-ago CNY491.2M

  • On Deck:

    • China:

      • Earnings:

        • Ganfeng Lithium Group (002460.CH), Walvax Biotechnology (300142.CH), Fujian Funeng (600483.CH), Huali Industrial Group (300979.CH), Beijing Tiantan Biological Products (600161.CH), Xiamen Tungsten (600549.CH)

    • Hong Kong:

      • Earnings:

        • C&D International Investment Group (1908.HK), China Vanke (2202.HK), Bloks Group (325.HK), Jiumaojiu International Holdings (9922.HK), Greentown Management Holdings (9979.HK), CSPC Pharmaceutical Group (1093.HK), Sinopharm Group (1099.HK), Brilliance China Automotive Holdings (1114.HK), East Buy Holding (1797.HK), Zhaojin Mining Industry (1818.HK), Ainnovation Technology Group Co. (2121.HK), Lepu Scientech Medical Technology (2291.HK), Minieye Technology (2431.HK), Marketingforce Management (2556.HK), Dida Inc. (2559.HK), China Everbright Environment Group (257.HK), Greentown Service Group (2869.HK), Beijing Tong Ren Tang Chinese Medicine (3613.HK), Zhuzhou CRRC Times Electric (3898.HK), Greentown China Holdings (3900.HK), Dongfeng Motor Group (489.HK), Gemdale Properties & Investment (535.HK), Zhejiang Expressway (576.HK), China Tobacco International (HK) (6055.HK), Zhou Liu Fu Jewellery (6168.HK), Star CM Holdings (6698.HK), ZJLD Group (6979.HK), Antengene (6996.HK), CIFI Holdings (Group) (884.HK), Viva Goods (933.HK), China Youran Dairy Group (9858.HK), ADICON Holdings (9860.HK), Dingdang Health Technology Group (9886.HK), Peijia Medical (9996.HK)

    • Japan:

      • Economic:

        • 08:30 JST: CPI Core National Y/Y; consensus

        • 08:30 JST: CPI National Y/Y; consensus +3.1%

        • 08:30 JST: CPI ex-Fresh Food and Energy; consensus +3.05%

    • Australia:

      • Earnings:

        • Resolute Mining (RSG.AU), Arovella Therapeutics (ALA.AU), Alkane Resources (ALK.AU), AMA Group (AMA.AU), Accent Group (AX1.AU), BCI Minerals (BCI.AU), BSP Financial Group (BFL.AU), Cobram Estate Olives (CBO.AU), Cuscal (CCL.AU), Coast Entertainment Holdings (CEH.AU), CogState (CGS.AU), DUG Technology (DUG.AU), Electro Optic Systems Holdings (EOS.AU), GQG Partners (GQG.AU), Guzman y Gomez (GYG.AU), Helia Group (HLI.AU), hipages Group Holdings (HPG.AU), Inghams Group (ING.AU), Latitude Group Holdings (LFS.AU), Rural Funds Group (RFF.AU), Zip Co (ZIP.AU), Michael Hill International (MHJ.AU), Monash IVF Group (MVF.AU)

    • Malaysia:

      • Economic:

        • 00:00 EST: CPI NSA Y/Y; consensus +1.2%

      • Earnings:

        • Kuala Lumpur Kepong (2445.MK)

    • Singapore:

      • Earnings:

        • Singapore Post (S08.SP)

  • Market Data:

    • Gold (Dec 25): +$0.70 or +0.02% to $3382.30

    • WTI Crude (Oct 25): ($0.03) or (0.05%) to $63.49

    • $-¥: +0.97 or +0.66% to 148.3000

    • $-KRW: +1.73 or +0.12% to 1399.6100

    • A$-$: (0.00) or (0.12%) to 0.6424

    • $-INR: +0.27 or +0.32% to 87.2935

    • $-CNY: +0.00 or +0.05% to 7.1795

  • If you would like to receive the Asian Market Preview daily, please search for Asia Pre-Market Updates in Alert Manager.

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE